{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:21:54Z","timestamp":1787840514183,"version":"build-2784847793"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Benign adrenal tumours are frequently seen in endocrinology, affecting mostly men in middle aged. But incidentalomas are more common in the elderly. Functional adrenal tumours most commonly secrete cortisol, aldosterone and very rarely, oestrogen. But if mixed secretion is present (most commonly cortisol and androgen), it is prudent to suspect adrenal cortical carcinoma (ACC), which in fact is rare &lt; 5% of all adrenal tumours. ACC-secreting estradiol is rarer, 1\u20132% of all adrenal tumours. Most feminizing adrenal tumours (FATs) are malignant with a very poor prognosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The study was a retrospective observational study conducted between January 2013\u2013December 2023. Data was retrieved from the hospital information system.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Out of 156 patient profiles screened for adrenal tumours, four were selected for analysis who had elevated estradiol levels. The mean age was 45 years, with all being males. Two patients had ACC and two had benign tumours. All four had painless gynaecomastia. Three patients had mild autonomous cortisol secretion (MACS) with worsening of diabetes, hypertension, and osteopenia. Estradiol levels were ranging from 301 to 3648 pmol\/L. CT abdomen showed average size of tumour being 10.7 cm. Two patients had distant metastases to lung, liver, and bone. All underwent adrenalectomy, and one of them received post-adjuvant chemotherapy. Patients with ACC had Weiss score of 6. Postoperatively, two patients had decreased estradiol.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>FATs are very rare in endocrinology, with most of them being ACC with a dire prognosis. Even with early diagnosis and treatment, the short-term survival is very poor.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijem.ijem_9_25","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T07:00:19Z","timestamp":1756278019000},"page":"429-433","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Feminizing Adrenal Tumour \u2013 A Case Series from a Tertiary Care Centre in Northern India"],"prefix":"10.4103","volume":"29","author":[{"given":"Prashant","family":"Hubballi","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhash","family":"Yadav","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti","family":"Dabadghao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"key":"R1-20250827","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0022-5347(01)67631-6","article-title":"Aromatase activity in an estrogenproducing adrenocortical carcinoma in a young man","volume":"153","author":"Kimura","year":"1995","journal-title":"J Urol"},{"key":"R2-20250827","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1210\/jc.2013-3020","article-title":"Update in adrenocortical carcinoma","volume":"98","author":"Fassnacht","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R3-20250827","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.mce.2011.09.009","article-title":"Wnt\/b-catenin signalling in adrenal physiology and tumour development","volume":"351","author":"Berthon","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"R4-20250827","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/er.2013-1029","article-title":"Adrenocortical carcinoma","volume":"35","author":"Else","year":"2014","journal-title":"Endocr Rev"},{"issue":"(Suppl 7)","key":"R5-20250827","doi-asserted-by":"crossref","first-page":"vii131","DOI":"10.1093\/annonc\/mds231","article-title":"Adrenal cancer:ESMO clinical practice guidelines fordiagnosis, treatment and follow-up","volume":"23","author":"Berruti","year":"2012","journal-title":"Ann Oncol"},{"key":"R6-20250827","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1507\/endocrj.47.723","article-title":"Estrogen secreting adrenal adenocarcinoma in an 18-month-old boy:Aromatase activity, protein expression, mRNA and utilization of gonadal type promoter","volume":"47","author":"Watanabe","year":"2000","journal-title":"Endocr J"},{"key":"R7-20250827","first-page":"16093","article-title":"Aromatase expression in the normal human adult ad- renal and in adrenocortical tumours:Biochemical, immunohistochemical, and molecular studies","author":"Moreau","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"R8-20250827","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.2169\/internalmedicine.50.4968","article-title":"Feminizing adrenocortical carcinoma with selective suppression of follicle-stimulating hormone secretion and disorganized steroidogenesis:A case report and literature review","volume":"50","author":"Saito","year":"2011","journal-title":"Intern Med"},{"key":"R9-20250827","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.mce.2008.10.032","article-title":"Estrogen biosynthesis in human H295 adrenocortical carcinoma cells","volume":"300","author":"Nicol","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"R10-20250827","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ccell.2016.07.013","article-title":"Comprehensive pan-genomic characterization of adrenocortical carcinoma","volume":"30","author":"Zheng","year":"2016","journal-title":"Cancer Cell"},{"key":"R11-20250827","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1158\/1078-0432.CCR-15-2256","article-title":"Identification of niclosamide as a novel anticancer agent for adrenocortical carcinoma","volume":"22","author":"Satoh","year":"2016","journal-title":"Clin Cancer Res"},{"key":"R12-20250827","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0140-6736(06)68699-6","article-title":"Cushing's syndrome","volume":"367","author":"Jewell-Price","year":"2006","journal-title":"Lancet"},{"key":"R13-20250827","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s11102-019-00960-0","article-title":"Non-functioning pituitary adenomas:Indications for pituitary surgery and post-surgical management","volume":"22","author":"Esposito","year":"2019","journal-title":"Pituitary"},{"key":"R14-20250827","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF03351068","article-title":"Adrenal tumours:How to establish malignancy?","volume":"27","author":"Fassnacht","year":"2004","journal-title":"J Endocrinol Invest"},{"key":"R15-20250827","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4103\/0377-4929.64325","article-title":"Weiss criteria in large adrenocortical tumours:A validation study","volume":"53","author":"Jain","year":"2010","journal-title":"Indian J Pathol Microbiol"},{"key":"R16-20250827","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas:European society of Endocrinology clinical practice guideline in collaboration with the European network for the study of adrenal tumours","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"R17-20250827","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0090-4295(00)00852-9","article-title":"Immunohistochemical assessment of Ki-67 in the differential diagnosis of adrenocortical tumours","volume":"57","author":"Terzolo","year":"2001","journal-title":"Urology"},{"key":"R18-20250827","doi-asserted-by":"crossref","first-page":"dgz284","DOI":"10.1210\/clinem\/dgz284","article-title":"Adrenal incidentalomas are tied to increased risk of diabetes:Findings from a prospective study","volume":"105","author":"Reimondo","year":"2020","journal-title":"J Clin Endocrinol Metabol"},{"key":"R19-20250827","first-page":"1440","article-title":"Subclinical Cushing's syndrome in patients with adrenal incidentaloma:Clinical and biochemical features","volume":"85","author":"Rossi","year":"2000","journal-title":"J Clin Endocrinol Metabol"},{"key":"R20-20250827","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1365-2265.2008.03492.x","article-title":"Hormonal activity of adrenal incidentalomas:Results from a long-term follow-up study","volume":"70","author":"Vassilatou","year":"2009","journal-title":"Clin Endocrinol"},{"key":"R21-20250827","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1200\/JCO.2010.31.4799","article-title":"Feminizing adrenal neoplasms:Case presentations and review of the literature","volume":"29","author":"Kidd","year":"2011","journal-title":"J Clin Oncol"},{"key":"R22-20250827","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1210\/jc.2018-00689","article-title":"Feminizing adrenocortical carcinoma:The source of estrogen production and the role of adrenal-gonadal dedifferentiation","volume":"103","author":"Wu","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"R23-20250827","doi-asserted-by":"crossref","first-page":"101491","DOI":"10.1016\/j.beem.2021.101491","article-title":"Assessment of mild autonomous cortisol secretion among incidentally discovered adrenal masses","volume":"35","author":"Yozamp","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"R24-20250827","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF03348975","article-title":"Feminization as a result of both peripheral conversion of androgens and direct estrogen production from an adrenocortical carcinoma","volume":"17","author":"Zayed","year":"1994","journal-title":"J Endocrinol Invest"},{"key":"R25-20250827","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0003-4266(06)72537-9","article-title":"Feminizing adreno-cortical carcinomas in male adults. A dire prognosis. Three cases in a series of 801 adrenalectomies and review of the literature","volume":"67","author":"Moreno","year":"2006","journal-title":"Ann Endocrinol (Paris)"},{"key":"R26-20250827","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1210\/jc.2005-2639","article-title":"Clinical review:Adrenocortical carcinoma:Clinical update","volume":"91","author":"Allolio","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R27-20250827","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1210\/jc.2013-2856","article-title":"Adjuvant therapies and patient and tumour characteristics associated with survival of adult patients with adrenocortical carcinoma","volume":"99","author":"Else","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"R28-20250827","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1210\/jc.2010-0990","article-title":"Approach to the patient with adrenocortical carcinoma","volume":"95","author":"Lacroix","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R29-20250827","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1677\/erc.1.01029","article-title":"Management of patients with adrenal cancer:Recommendations of an international consensus conference","volume":"12","author":"Schteingart","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"R30-20250827","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","article-title":"Wnt\/\u03b2-catenin signalling:Function, biological mechanisms, and therapeutic opportunities","volume":"7","author":"Liu","year":"2022","journal-title":"Signal Transduct Target Ther"}],"container-title":["Indian Journal of Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijem.ijem_9_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:24:14Z","timestamp":1787837054000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijem.ijem_9_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/ijem.ijem_9_25","relation":{},"ISSN":["2230-8210","2230-9500"],"issn-type":[{"value":"2230-8210","type":"print"},{"value":"2230-9500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"2025-01-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}